These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27014972)

  • 1. In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.
    Li X; Jiang J; Zhao X; Zhao Y; Cao Q; Zhao Q; Han H; Wang J; Yu Z; Peng B; Ying W; Qian X
    Oncotarget; 2016 Apr; 7(16):22031-49. PubMed ID: 27014972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry.
    Li X; Jiang J; Zhao X; Wang J; Han H; Zhao Y; Peng B; Zhong R; Ying W; Qian X
    PLoS One; 2013; 8(12):e81921. PubMed ID: 24324730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.
    Chen N; Sun W; Deng X; Hao Y; Chen X; Xing B; Jia W; Ma J; Wei H; Zhu Y; Qian X; Jiang Y; He F
    Proteomics; 2008 Dec; 8(23-24):5108-18. PubMed ID: 19016532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
    Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
    Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
    Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysing protein-protein interaction networks of human liver cancer cell lines with diverse metastasis potential.
    Zhou HJ; Liu YK; Li Z; Yun D; Shun QL; Guo K
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):663-72. PubMed ID: 17458561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
    Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CXCR3 in hepatocellular carcinoma].
    Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
    Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-parallel N-glycopeptide enrichment strategy for high-throughput and in-depth mapping of the N-glycoproteome in metastatic human hepatocellular carcinoma cell lines.
    Jiang B; Huang J; Yu Z; Wu M; Liu M; Yao J; Zhao H; Yan G; Ying W; Cao W; Yang P
    Talanta; 2019 Jul; 199():254-261. PubMed ID: 30952254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and significance of vascular endothelial growth factor and its receptors in hepatocellular carcinoma cell lines with various metastatic potentialities].
    Ai JH; Zheng SG; Zeng YY; Xiong Y; Zhang LD; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):105-8. PubMed ID: 18304425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.